| 6:07 pm Black Hills Corp utility subsidiary announces submission of applications with respective state utility regulators seeking approval for a Cost of Service Gas Program | |
| | |
|
5:48 am European Markets : FTSE...6151.60...+79.10...+1.30%. DAX...9623.08...+113.80...+1.20%. 5:48 am Asian Markets : Nikkei...17725.13...+2.70...+0.00%. Hang Seng...21506.09...+659.80...+3.20%. 5:46 am Riverview Bancorp, Inc. increases quarterly dividend to $0.015/share from $0.0125/share (RVSB) : 4:11 am Realty Income prices 10,000,000 shares of common stock at $46.88 per share (O) : 4:08 am DISH Network issues statement updating AWS-3 Spectrum; Northstar Wireless and SNR Wireless are expected to be granted licenses (DISH) : Co issued the following statement: - "Today, the two entities in which DISH invested with respect to the AWS-3 auction -- Northstar Wireless and SNR Wireless -- entered into a series of arrangements in connection with which the FCC will retain certain licenses for which Northstar and SNR were the winning bidders, and the FCC will apply funds already on deposit and newly-loaned funds from a subsidiary of DISH toward the payment of the gross winning bids for the remaining licenses, which cover approximately 6.6 billion MHz-POPs..."
3:51 am Novartis unit Sandoz receives FDA submission acceptance for its proposed biosimilar etanercept (NVS) : Sandoz, a Novartis company and the global leader in biosimilars, announced today that the FDA has accepted its Biologics License Application under the 351 (k) pathway for its proposed biosimilar to Amgen's US-licensed Enbrel - a tumor necrosis factor alpha inhibitor. - Sandoz believes that the two pivotal clinical studies; a pharmacokinetic study in healthy volunteers and a confirmatory safety and efficacy study in patients with chronic plaque-type psoriasis, will provide confirmation of similarity to the reference product established in prior analytical comparability investigations.
3:04 am Immune Pharma secures $3 mln tranche from Discover Growth Fund (IMNP) : Immune Pharmaceuticals announced that it has received an additional $3 million in gross proceeds from Discover Growth Fund pursuant prior agreement previously disclosed. - This financing was in addition to the gross proceeds of $9 million already received from Discover at the same $2.50 conversion price and terms and the $4.5 million from Hercules Technology Growth Capital.
- The additional $3 million from Discover was received upon an effective "resale" registration statement pertaining to the Series D Preferred and stockholders approval on Friday, September 25, 2015.
|
|
|
Black Hills Corporation
|
|
|
CODE : BKH |
ISIN : US0921131092 |
|
| |
ProfileMarket IndicatorsVALUE : Projects & res.Press releasesAnnual reportRISK : Asset profileContact Cpy |
Black Hills is a producing company based in United states of america. Black Hills is listed in Germany and in United States of America. Its market capitalisation is US$ 2.9 billions as of today (€ 2.6 billions). Its stock quote reached its lowest recent point on April 11, 1986 at US$ 1.27, and its highest recent level on February 07, 2020 at US$ 87.12. Black Hills has 53 544 761 shares outstanding. |